Abstract Details

Title Determination of the Minimal Clinically Important Difference (MCID) in Seizure Frequency in Three Phase III Trials of Adjunctive Eslicarbazepine Acetate (ESL) for Partial-onset (Focal) Seizures (POS)

Topic Epilepsy/Clinical Neurophysiology (EEG)

Presentation(s) P5 - (-)

Poster/Presentation
Number 275

Objective

Background

Design/Methods

Results

Conclusions

Authors/Disclosures
Hailong Cheng PRESENTER	No disclosure on file
	No disclosure on file
	No disclosure on file

��ɫ��

��ɫ��

Abstract Details

��ɫ����

��ɫ����

��ɫ��

��ɫ��